0001209191-22-062125.txt : 20221220 0001209191-22-062125.hdr.sgml : 20221220 20221220132953 ACCESSION NUMBER: 0001209191-22-062125 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221216 FILED AS OF DATE: 20221220 DATE AS OF CHANGE: 20221220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAMSAY DAVID A CENTRAL INDEX KEY: 0001283292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 221474064 MAIL ADDRESS: STREET 1: HALOZYME THERAPEUTICS, INC. STREET 2: 11588 SORRENTO VALLEY ROAD, #17 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-16 0 0001160308 Savara Inc SVRA 0001283292 RAMSAY DAVID A 6836 BEE CAVE ROAD BUILDING III, SUITE 201 AUSTIN TX 78746 1 0 0 0 Common Stock 2022-12-16 4 P 0 341 1.50 A 1946593 D Common Stock 2022-12-19 4 P 0 40719 1.494 A 1987312 D Common Stock 2022-12-20 4 P 0 13830 1.501 A 2001142 D The price is a weighted average purchase price. The purchase prices ranged from $1.47 to $1.52. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. The price is a weighted average purchase price. The purchase prices ranged from $1.485 to $1.53. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. /s/ David Ramsay 2022-12-20